Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NPA101.3 is a a Second-Generation RET/VEGFR2 Inhibitor. It is a potential clinical candidate for RET-driven cancers.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | NPA101.3 is a a Second-Generation RET/VEGFR2 Inhibitor. It is a potential clinical candidate for RET-driven cancers. |
Molecular Weight | 528.62 |
Formula | C29H28N4O4S |
CAS No. | 1839155-15-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NPA101.3 1839155-15-5 TPP 2a TPP-2a inhibitor inhibit